(Q46702254)

24 December 2017

title

Proteasome inhibitor does not enhance MPTP neurotoxicity in mice (English)

1 reference

24 December 2017

1 reference

1 reference

Naoto Kadoguchi

1

1 reference

24 December 2017

Masahiro Umeda

series ordinal

2

1 reference

24 December 2017

Hiroyuki Kato

series ordinal

3

1 reference

24 December 2017

Tsutomu Araki

series ordinal

4

1 reference

24 December 2017

publication date

14 March 2008

1 reference

24 December 2017

Cellular and Molecular Neurobiology

published in

1 reference

24 December 2017

volume

28

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

971-979

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s10571-008-9271-4

exact match

0 references

cites work

Aquatic actinomycetes: a critical survey of the occurrence, growth and role of actinomycetes in aquatic habitats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10571-008-9271-4

Neuroprotective effect of riluzole in MPTP-treated mice

21 January 2018

1 reference

12 December 2020

Neuroprotection for Parkinson's disease: prospects and promises

1 reference

12 December 2020

Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture

1 reference

12 December 2020

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

1 reference

12 December 2020

Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

1 reference

12 December 2020

Altered proteasomal function in sporadic Parkinson's disease

1 reference

12 December 2020

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

1 reference

12 December 2020

Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology.

1 reference

12 December 2020

Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.

1 reference

12 December 2020

Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia

1 reference

12 December 2020

Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species

1 reference

12 December 2020

Systemic proteasomal inhibitor exposure enhances dopamine turnover and decreases dopamine levels but does not affect MPTP-induced striatal dopamine depletion in mice

1 reference

12 December 2020

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

12 December 2020

Expression of S-100 protein is related to neuronal damage in MPTP-treated mice

1 reference

12 December 2020

Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway.

1 reference

12 December 2020

High susceptibility to cerebral ischemia in GFAP-null mice

1 reference

12 December 2020

Physiology of some actinomycete genera.

1 reference

12 December 2020

Participation of the 26S proteasome in the regulation of progesterone receptor concentrations in the rat brain

1 reference

12 December 2020

Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition

1 reference

12 December 2020

TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities.

1 reference

12 December 2020

Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo

1 reference

12 December 2020

Oxidative stress in Parkinson's disease

1 reference

12 December 2020

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

1 reference

12 December 2020

Proteasome inhibition and Parkinson's disease modeling

1 reference

12 December 2020

Lactacystin, proteasome function, and cell fate

1 reference

12 December 2020

Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system

1 reference

12 December 2020

Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons.

1 reference

12 December 2020

Failure of proteasome inhibitor administration to provide a model of Parkinson's disease in rats and monkeys.

1 reference

12 December 2020

Proteasome inhibitors: from research tools to drug candidates

1 reference

12 December 2020

Proteasome inhibition induces glutathione synthesis and protects cells from oxidative stress: relevance to Parkinson disease

1 reference

12 December 2020

A natural musaceas plant extract inhibits proteasome activity and induces apoptosis selectively in human tumor and transformed, but not normal and non-transformed, cells

1 reference

12 December 2020

Environmental risk factors and Parkinson's disease: a metaanalysis.

1 reference

12 December 2020

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

12 December 2020

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

12 December 2020

Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity.

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice

1 reference

12 December 2020

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

1 reference

12 December 2020

Parkinson's disease: mechanisms and models

1 reference

12 December 2020

10.1007/S10571-008-9271-4

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017